by Krystal Jacques | May 29, 2025
Imagine a one-and-done treatment for stroke using the regenerative capacity of your brain. Tianhao Chen, Dr. Cindi Morshead’s lab, and Dr. Hani E. Naguib’s lab have developed a biodegradable electrode that can electrically stimulate neural precursor cells (NPCs). This...
by Peace Chukwu | Jan 10, 2025
A challenge in stem cell research and clinical application is the imbalance between demand and the limited availability of these stem cells. This shortage complicates the development of effective therapies and restricts treatment options for patients. Because stem...
by Lyla El-Fayomi | Dec 26, 2024
Pick of the Month Another HIV-1 remission, but with a twist: The Geneva Patient I previously wrote about Mr. Paul Edmonds, who was the fifth person in history to be cured of both HIV-1 and leukemia since the first such case in 2009. This was achieved through a...
by Stacey Johnson | Oct 25, 2024
Michel Sadelain is the 2024 Gairdner International Award laureate, along with Dr. Zelig Eshhar, for his “seminal contributions to the conception, development and application of CD19-CAR T cell therapy for cancer.” It’s been a good year for Dr. Sadelain, who also won...
by Kevin Robb | Aug 22, 2024
Last month, the U.S. Food and Drug Administration (FDA) agreed to formally review a revised Biologics License Application (BLA) from Mesoblast for their mesenchymal stromal cell (MSC) product, remestemcel-L. The submission represents the third attempt by the company...
by Medicine by Design | Aug 6, 2024
CCRM, the publisher of Signals, has enhanced its long-standing relationship with the University of Toronto’s Medicine by Design through a new strategic alliance. This profile is one in a series of profiles that feature “people” of Medicine by Design. Some minor edits...
Comments